Inhibitor Therapeutics announces annual shareholder meeting

Reuters2026/08/17 12:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Inhibitor Therapeutics schedules a virtual annual stockholder meeting on Sept. 15, 2026, held via the internet.
Items include election of six directors, covering Francis E. O'Donnell, Samuel J. Sears, Niraj Vasisht, plus three others.
Shareholders will vote on ratifying Cherry Bekaert as independent auditor for fiscal 2026.
Ballot also covers approval of the 2025 equity incentive plan, an advisory say-on-pay vote, plus the frequency of future say-on-pay votes.
Additional proposal seeks authorization to adjourn the meeting if needed to secure sufficient votes on the other items.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inhibitor Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-038636), on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Inhibitor Therapeutics announces annual shareholder meeting

You may also like

Crypto prices